Condensed Consolidated Balance Sheets - USD ($) $ in Thousands		Jun. 30, 2022	Dec. 31, 2021
Current assets
Cash and cash equivalents		$ 80,598	$ 124,782	[1]
Available-for-sale securities, current		174,945	158,973	[1]
Accounts receivable, net		12,589	11,888	[1]
Inventories, net current		28,692	23,075	[1]
Prepaid expenses and other current assets		14,647	12,705	[1]
Total current assets		311,471	331,423	[1]
Available-for-sale securities, non-current		32,431	102,878	[1]
Internally developed software, net		14,348	11,005	[1]
Inventories, net non-current		8,425	0
Property and equipment, net		2,947	2,039	[1]
Other non-current assets		2,933	2,256	[1]
Total assets		372,555	449,601	[1]
Current liabilities
Accounts payable		8,096	6,517	[1]
Accrued expenses		29,373	24,309	[1]
Deferred revenue, current		9,919	7,259	[1]
Other current liabilities		1,373	4,528	[1]
Total current liabilities		48,761	42,613	[1]
Deferred revenue, non-current		30,803	23,209	[1]
Warrant liability		821	9,787	[1]
Other non-current liabilities		141	0	[1]
Total liabilities		80,526	75,609	[1]
Commitments and contingencies (see Note 9)
Stockholders’ Equity
Common stock - $0.0001 par value, 1,000,000,000 shares authorized; 144,086,282 and 141,585,530 shares issued and outstanding as of June 30, 2022 and December 31, 2021, respectively	[2]	16	15	[1]
Additional paid-in-capital		724,285	705,865	[1]
Accumulated other comprehensive loss		(2,574)	(676)	[1]
Accumulated deficit		(429,698)	(331,212)	[1]
Total stockholders’ equity		292,029	373,992	[1]
Total liabilities and stockholders’ equity		$ 372,555	$ 449,601	[1]

[1] Restated amounts, including any adjustments to previously reported amounts, are presented in Note 2. Restatement of Prior Period Financial Statements and Information.

[2] Shares issued and outstanding as of June 30, 2022 and December 31, 2021 exclude 738,000 shares subject to vesting requirements. See Note 1. Description of Business.